Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Vascular smooth muscle–specific YAP/TAZ deletion triggers aneurysm development in mouse aorta
Marycarmen Arévalo Martínez, Olivia Ritsvall, Joakim Armstrong Bastrup, Selvi Celik, Gabriel Jakobsson, Fatima Daoud, Christopher Winqvist, Anders Aspberg, Catarina Rippe, Lars Maegdefessel, Alexandru Schiopu, Thomas A. Jepps, Johan Holmberg, Karl Swärd, Sebastian Albinsson
Marycarmen Arévalo Martínez, Olivia Ritsvall, Joakim Armstrong Bastrup, Selvi Celik, Gabriel Jakobsson, Fatima Daoud, Christopher Winqvist, Anders Aspberg, Catarina Rippe, Lars Maegdefessel, Alexandru Schiopu, Thomas A. Jepps, Johan Holmberg, Karl Swärd, Sebastian Albinsson
View: Text | PDF
Research Article Cell biology Vascular biology

Vascular smooth muscle–specific YAP/TAZ deletion triggers aneurysm development in mouse aorta

  • Text
  • PDF
Abstract

Inadequate adaption to mechanical forces, including blood pressure, contributes to development of arterial aneurysms. Recent studies have pointed to a mechanoprotective role of YAP and TAZ in vascular smooth muscle cells (SMCs). Here, we identified reduced expression of YAP1 in human aortic aneurysms. Vascular SMC–specific knockouts (KOs) of YAP/TAZ were thus generated using the integrin α8–Cre (Itga8-Cre) mouse model (i8-YT-KO). i8-YT-KO mice spontaneously developed aneurysms in the abdominal aorta within 2 weeks of KO induction and in smaller arteries at later times. The vascular specificity of Itga8-Cre circumvented gastrointestinal effects. Aortic aneurysms were characterized by elastin disarray, SMC apoptosis, and accumulation of proteoglycans and immune cell populations. RNA sequencing, proteomics, and myography demonstrated decreased contractile differentiation of SMCs and impaired vascular contractility. This associated with partial loss of myocardin expression, reduced blood pressure, and edema. Mediators in the inflammatory cGAS/STING pathway were increased. A sizeable increase in SOX9, along with several direct target genes, including aggrecan (Acan), contributed to proteoglycan accumulation. This was the earliest detectable change, occurring 3 days after KO induction and before the proinflammatory transition. In conclusion, Itga8-Cre deletion of YAP and TAZ represents a rapid and spontaneous aneurysm model that recapitulates features of human abdominal aortic aneurysms.

Authors

Marycarmen Arévalo Martínez, Olivia Ritsvall, Joakim Armstrong Bastrup, Selvi Celik, Gabriel Jakobsson, Fatima Daoud, Christopher Winqvist, Anders Aspberg, Catarina Rippe, Lars Maegdefessel, Alexandru Schiopu, Thomas A. Jepps, Johan Holmberg, Karl Swärd, Sebastian Albinsson

×

Figure 8

Loss of SMC differentiation and arterial contractility in i8-YT-KO mice at 8 weeks.

Options: View larger image (or click on image) Download as PowerPoint
Loss of SMC differentiation and arterial contractility in i8-YT-KO mice ...
(A) Proteins with a role in SMC contraction that were significantly reduced in the proteomic experiment at 8 weeks after tamoxifen. Several of these, including integrin α8 (ITGA8), calponin-1 (CNN1), transgelin (SM22α), membrane primary amine oxidase (SSAO), and myosin light chain kinase (MLCK), are targets of the transcription factor myocardin (Myocd), the master regulator of SMC differentiation. To examine contractility, we mounted caudal arteries in Mulvany myographs and applied a basal tension of 5 mN. FC, fold change. (B) Shows that the internal circumference was greater in i8-YT-KO mice compared with controls (Ctrl) at 5 mN (n ≥ 18 mice and 38 arteries). (C–E) Following equilibration, arteries were stimulated with 60 mM K+ (C, n ≥ 18 mice and 38 arteries), the α1-adrenergic receptor agonist cirazoline (D, n ≥ 10 mice and 20 arteries), and vasopressin (E, n ≥ 10 mice and 20 arteries). Preparations were washed and maintained in a relaxed state for 25 minutes between stimuli. Transcriptomic data indicated reduced expression of Myocd at 8 weeks after tamoxifen. (F) This reduced expression was confirmed using RT-qPCR in time-course studies of the aorta (n ≥ 4). (G and H) Parallel reduction of Acta2 (G, n ≥ 4) and Mylk (H, n ≥ 4) was observed. (I) Western blot for MLCK using 8-week aortae along with quantification of the bands at 210 and 130 kDa (n = 3). (J) MLCK in caudal arteries at 8 weeks (n ≥ 6). (K) Reduction in smooth muscle myosin heavy chain (MYH11) was also confirmed by Western blotting (n = 3). (L) Results from the Godet test (n ≥ 6). This test measures time taken (in seconds) for skin to rebound from pitting and is considered an indication of edema. *P < 0.05; **P < 0.01; ***P < 0.001 by Mann-Whitney test (B and L), 2-tailed Student’s t test (C and F–K), or 2-way ANOVA with Bonferroni’s post hoc test (D and E).

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts